Government ContextGovernment Context
DocumentsDocuments by topicDocuments by agencyPricingLog inCreate account
Nonrulemaking

Request that the FDA determine and declare that Buspirone Capsules 2.5 mg, 12.5 mg, 20 mg and 30 mg is suitable for submission in an Abbreviated New Drug Application (ANDA)

🏛 Food and Drug Administration (FDA)FDA-2026-P-7195
Documents
7
Total comments
0
all analyzed
Comment status
Open
Last activity
—
In this docket

Documents

Rules, notices, and supporting material — the primary rule pinned first.

All 7Supporting & Related Material 5Other 2
📄 Primary document
OtherJun 30, 2026
Suitability Petition from Senores Pharmaceuticals, Inc
No comment period
Open →